This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Equine Interleukin-2 (IL2), N-Met
Product Overview
BioVenic's Recombinant Equine Interleukin-2 (IL2), N-Met is a recombinant protein expressed from CHO Cell. Its predicted molecular weight is 15.0 kDa. The purity is>97% (SDS-PAGE).
Specifications
Target Information
Equine interleukin-2 (IL-2) is a potent immunoregulatory cytokine that plays a central role in the activation and proliferation of T cells, as well as the differentiation of B cells and natural killer cells. In horses, IL-2 is primarily produced by CD4+ T cells and is crucial for the immune response to various antigenic stimuli. It is also used in therapeutic applications, such as in the treatment of equine sarcoids, where it has been shown to induce tumor regression when combined with chemotherapy.
Shipping and Storage
This product is shipped with dry ice. It is recommended to aliquote as needed and store at -80°C upon receipt. Reconstituted protein solution can be stored at 4°C for 1 week, at < -80°C for 12 months.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL.Aliquote the reconstituted solution to minimise freeze-thaw cycles.